Cost-effectiveness of asenapine in the treatment of bipolar disorder in Canada

Por Lachaine, Jean, Beauchemin, Catherine, Mathurin, Karine, Gilbert, Dominique, Beillat, Maud
Publicado em 2014

A health economic model for evaluating a vaccine for the prevention of herpes zoster and post-herpetic neuralgia in the UK

Por Moore, Lee, Remy, Vanessa, Martin, Monique, Beillat, Maud, McGuire, Alistair
Publicado em 2010

Efficacy, tolerability, and safety of aripiprazole once-monthly versus other long-acting injectable antipsychotic therapies in the maintenance treatment of schizophrenia: a mixed t...

Por Majer, Istvan M., Gaughran, Fiona, Sapin, Christophe, Beillat, Maud, Treur, Maarten
Publicado no J Mark Access Health Policy (2015)

Pharmacoeconomic comparison of aripiprazole once-monthly and paliperidone palmitate from a head-to-head clinical trial in schizophrenia: a US analysis

Por Sapin, Christophe, Hartry, Ann, Kamat, Siddhesh A., Beillat, Maud, Baker, Ross A., Eramo, Anna
Publicado no Drugs Context (2016)

Cost-Effectiveness of Gliclazide-Based Intensive Glucose Control vs. Standard Glucose Control in Type 2 Diabetes Mellitus. An Economic Analysis of the ADVANCE Trial in Vietnam

Por Nguyen-Thi, Hai-Yen, Nguyen, Nga TQ., Le, Nguyen Dang Tu, Beillat, Maud, Ethgen, Olivier
Publicado no Front Public Health (2020)

Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: A retrospective, population-based study

Por Serradell Laurence, Beillat Maud, Naldi Luigi, Gatti Antonio, Pezzotti Patrizio, Merito Monica, Gialloreti Leonardo, di Marzo Rafaelle, Volpi Antonio
Publicado em 2010-08-01

Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: A retrospective, population-based study

Por Gialloreti, Leonardo Emberti, Merito, Monica, Pezzotti, Patrizio, Naldi, Luigi, Gatti, Antonio, Beillat, Maud, Serradell, Laurence, di Marzo, Rafaelle, Volpi, Antonio
Publicado em 2010

Reduced sexual dysfunction with aripiprazole once-monthly versus paliperidone palmitate: results from QUALIFY

Por Potkin, Steven G., Loze, Jean-Yves, Forray, Carlos, Baker, Ross A., Sapin, Christophe, Peters-Strickland, Timothy, Beillat, Maud, Nylander, Anna-Greta, Hertel, Peter, Steen Andersen, Henrik, Eramo, Anna, Hansen, Karina, Naber, Dieter
Publicado no Int Clin Psychopharmacol (2017)

Multidimensional Assessment of Functional Outcomes in Schizophrenia: Results From QUALIFY, a Head-to-Head Trial of Aripiprazole Once-Monthly and Paliperidone Palmitate

Por Potkin, Steven G., Loze, Jean-Yves, Forray, Carlos, Baker, Ross A, Sapin, Christophe, Peters-Strickland, Timothy, Beillat, Maud, Nylander, Anna-Greta, Hertel, Peter, Nitschky Schmidt, Simon, Eramo, Anna, Hansen, Karina, Naber, Dieter
Publicado no Int J Neuropsychopharmacol (2016)

Relationship between response to aripiprazole once-monthly and paliperidone palmitate on work readiness and functioning in schizophrenia: A post-hoc analysis of the QUALIFY study

Por Potkin, Steven G., Loze, Jean-Yves, Forray, Carlos, Baker, Ross A., Sapin, Christophe, Peters-Strickland, Timothy, Beillat, Maud, Nylander, Anna-Greta, Hertel, Peter, Nitschky Schmidt, Simon, Ettrup, Anders, Eramo, Anna, Hansen, Karina, Naber, Dieter
Publicado no PLoS One (2017)

PM417. Relationship between response to aripiprazole once-monthly and paliperidone palmitate on work readiness and functioning: a post-hoc analysis of QUALIFY, a head-to-head study...

Por Salzman, Phyllis, Baker, Ross A., Beillat, Maud, Eramo, Anna, Forray, Carlos, Hansen, Karina, Hertel, Peter, Loze, Jean-Yves, Naber, Dieter, Schmidt, Simon Nitschky, Nylander, Anna-Greta, Peters-Strickland, Timothy, Potkin, Steven G., Sapin, Christophe
Publicado no Int J Neuropsychopharmacol (2016)